Commission Implementing Regulation (EU) 2023/741 of 5 April 2023 concerning the non-renewal of the approval of the active substance oxamyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)

Articolo 3Transitional measures

In vigore · versione del 11 apr 2023

Citenza

Intelligenza giuridica con fonti verificabili, di Datons.

citenza.io